Thermo Fisher Reports 22 Percent Revenue Growth for Q2, Raises Guidance for 2018

Jul 25, 2018

|

This article has been updated with additional comments from Thermo Fisher Scientific's earnings call.

NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 22 percent increase in second-quarter revenues that was partly driven by acquisitions and increased its revenue and earnings guidance for the year for the second time in a row.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Thermo Fisher Reports 22 Percent Revenue Growth for Q2, Raises Guidance for 2018

To read the full story....

Breaking News

PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

Ethos Labs, Agena Biosciences Partner on SARS-CoV-2 Variant Identification

Danaher Expects Q1 2021 Revenue Growth Above Previous Guidance

Australian Firm AnteoTech Obtains CE Marking for COVID-19 Antigen Test, Reader

Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

What's Popular?

DiaSorin to Acquire Luminex for $1.8B

Siemens Healthineers Gets CE Mark for Point-of-Care High-Sensitivity Cardiac Troponin I Test

Thermo Fisher Scientific Gets FDA EUA for High-Throughput, Automated COVID-19 Test Kit

Danaher Expects Q1 2021 Revenue Growth Above Previous Guidance

Ortho Clinical Diagnostics Gets Additional CE Mark for Coronavirus Antigen Test

Sponsorships